352 related articles for article (PubMed ID: 16882098)
1. The Anglo-Scandinavian Cardiac Outcomes Trial-- blood pressure lowering arm.
Coleman JJ; Kendall MJ
J Clin Pharm Ther; 2006 Aug; 31(4):299-307. PubMed ID: 16882098
[No Abstract] [Full Text] [Related]
2. Diabetes and hypertension: which is the best approach?
Escobar C; Barrios V
Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):269-71. PubMed ID: 19296764
[TBL] [Abstract][Full Text] [Related]
3. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Gupta AK; Dahlof B; Dobson J; Sever PS; Wedel H; Poulter NR;
Diabetes Care; 2008 May; 31(5):982-8. PubMed ID: 18235048
[TBL] [Abstract][Full Text] [Related]
4. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Collier DJ; Poulter NR; Dahlöf B; Sever PS; Wedel H; Buch J; Caulfield MJ;
J Hypertens; 2011 Mar; 29(3):583-91. PubMed ID: 21297503
[TBL] [Abstract][Full Text] [Related]
5. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
[TBL] [Abstract][Full Text] [Related]
7. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
van den Meiracker AH; van Montfrans GA
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
[TBL] [Abstract][Full Text] [Related]
8. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
10. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Ostergren J; Poulter NR; Sever PS; Dahlöf B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E;
J Hypertens; 2008 Nov; 26(11):2103-11. PubMed ID: 18854748
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive treatment and CHD in the elderly.
Fink KS; Ellsworth A
Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
[No Abstract] [Full Text] [Related]
12. Will ASCOT change the form of anti-hypertensive therapy?
Bilous R
Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
[No Abstract] [Full Text] [Related]
13. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
[TBL] [Abstract][Full Text] [Related]
14. Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.
Manisty CH; Zambanini A; Parker KH; Davies JE; Francis DP; Mayet J; McG Thom SA; Hughes AD;
Hypertension; 2009 Oct; 54(4):724-30. PubMed ID: 19704107
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)].
Widimský J
Vnitr Lek; 2005 Dec; 51(12):1394-6, 1398-9. PubMed ID: 16430107
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
17. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.
Sever P; Dahlöf B; Poulter N; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen S; Kristinsson A; McInnes G; Mehlsen J; Nieminem M; O'Brien E; Ostergren J;
Eur Heart J; 2006 Dec; 27(24):2982-8. PubMed ID: 17145722
[TBL] [Abstract][Full Text] [Related]
18. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
[TBL] [Abstract][Full Text] [Related]
19. [Amlodipine better than atenolol in hypertension. More efficient prevention of the mortality and cardiovascular events according to the ASCOT trial].
Nilsson PM; Håkansson J
Lakartidningen; 2005 Oct 10-16; 102(41):2922-3. PubMed ID: 16294509
[No Abstract] [Full Text] [Related]
20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
